Fighting blindness with gene therapy

Shannon E. Boye, PhD ’06, has an eye for tackling some of the toughest sight-robbing vision problems.

By Doug Bennett
Dr. Shannon Boye Shannon Boye, PhD, an associate professor in the University of Florida’s department of ophthalmology, was recently awarded funding from Genzyme, a division of Sanofi, to develop a treatment for a severe form of childhood blindness called Leber congenital amaurosis-1 (LCA1). Photo by Jesse S. Jones

Learn more about Dr. Boye's research

Video by Chris Bilowich